Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-03-30

AUTHORS

R Takimoto, W S El-Deiry

ABSTRACT

KILLER/DR5, a tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor gene, has been shown to be induced by DNA damaging agents and radiation in a p53-dependent manner. Although TRAIL is a potential therapeutic agent for cancer, the induction mechanism of its receptors is poorly understood. Here we show the identification of three p53 DNA-binding sites in the KILLER/DR5 genomic locus located upstream (BS1; −0.82 Kb) of the ATG site, within Intron 1 (BS2; +0.25 Kb downstream of the ATG) and within Intron 2 (BS3; +1.25 Kb downstream of the ATG). A modified p53-binding and immunoselection protocol using a wild-type p53-expressing adenovirus vector (Ad-p53) was used to identify the binding sites and to show that each binding site can bind specifically to wild-type p53 protein (wt-p53). A reporter assay revealed that only BS2 could enhance luciferase expression driven by a basal promoter. We constructed a reporter plasmid carrying the genomic regulatory region of KILLER/DR5 including the three p53 DNA-binding sites but no additional basal promoter. The genomic fragment showed basal transcriptional activity which was induced by wt-p53 but not by mutant p53, and human papilloma virus E6 inhibited the p53-dependent activation. Mutation of BS2 abrogated not only the binding activity of wt-p53 but also the induction of the KILLER/DR5 genomic promoter-reporter gene, indicating that BS2 is responsible for the p53-dependent transactivation of KILLER/DR5. In p53-wild-type but not -mutant or -null cell lines, doxorubicin treatment stabilized p53 protein, and increased specific binding to BS2 as revealed by EMSA, and upregulated the KILLER/DR5 promoter-luciferase reporter gene. These results suggest that the transactivation of KILLER/DR5 is directly regulated by exogenous or endogenous wt-p53 and establishes KILLER/DR5 as a p53 target gene that can signal apoptotic death. More... »

PAGES

1735-1743

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1203489

DOI

http://dx.doi.org/10.1038/sj.onc.1203489

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045600742

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10777207


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Binding Sites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Damage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, Reporter", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Introns", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutagenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncogene Proteins, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Promoter Regions, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, TNF-Related Apoptosis-Inducing Ligand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Tumor Necrosis Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcriptional Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takimoto", 
        "givenName": "R", 
        "id": "sg:person.01156250213.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156250213.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Center and the Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA", 
            "Department of Medicine, Pharmacology, and Genetics, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA", 
            "Cancer Center and the Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "El-Deiry", 
        "givenName": "W S", 
        "id": "sg:person.01320537310.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320537310.58"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1203025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032194524", 
          "https://doi.org/10.1038/sj.onc.1203025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng1097-141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040087526", 
          "https://doi.org/10.1038/ng1097-141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201264", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015577678", 
          "https://doi.org/10.1038/sj.onc.1201264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0492-45", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003183829", 
          "https://doi.org/10.1038/ng0492-45"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036533215", 
          "https://doi.org/10.1038/sj.onc.1201002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/362857a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008690526", 
          "https://doi.org/10.1038/362857a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0396-255a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018355242", 
          "https://doi.org/10.1038/nm0396-255a"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/38525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023661637", 
          "https://doi.org/10.1038/38525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201755", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043632183", 
          "https://doi.org/10.1038/sj.onc.1201755"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-03-30", 
    "datePublishedReg": "2000-03-30", 
    "description": "KILLER/DR5, a tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor gene, has been shown to be induced by DNA damaging agents and radiation in a p53-dependent manner. Although TRAIL is a potential therapeutic agent for cancer, the induction mechanism of its receptors is poorly understood. Here we show the identification of three p53 DNA-binding sites in the KILLER/DR5 genomic locus located upstream (BS1; \u22120.82\u2009Kb) of the ATG site, within Intron 1 (BS2; +0.25\u2009Kb downstream of the ATG) and within Intron 2 (BS3; +1.25\u2009Kb downstream of the ATG). A modified p53-binding and immunoselection protocol using a wild-type p53-expressing adenovirus vector (Ad-p53) was used to identify the binding sites and to show that each binding site can bind specifically to wild-type p53 protein (wt-p53). A reporter assay revealed that only BS2 could enhance luciferase expression driven by a basal promoter. We constructed a reporter plasmid carrying the genomic regulatory region of KILLER/DR5 including the three p53 DNA-binding sites but no additional basal promoter. The genomic fragment showed basal transcriptional activity which was induced by wt-p53 but not by mutant p53, and human papilloma virus E6 inhibited the p53-dependent activation. Mutation of BS2 abrogated not only the binding activity of wt-p53 but also the induction of the KILLER/DR5 genomic promoter-reporter gene, indicating that BS2 is responsible for the p53-dependent transactivation of KILLER/DR5. In p53-wild-type but not -mutant or -null cell lines, doxorubicin treatment stabilized p53 protein, and increased specific binding to BS2 as revealed by EMSA, and upregulated the KILLER/DR5 promoter-luciferase reporter gene. These results suggest that the transactivation of KILLER/DR5 is directly regulated by exogenous or endogenous wt-p53 and establishes KILLER/DR5 as a p53 target gene that can signal apoptotic death.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1203489", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2435689", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "14", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "DNA-binding sites", 
      "KILLER/DR5", 
      "p53 DNA-binding sites", 
      "basal promoter", 
      "promoter-luciferase reporter gene", 
      "genomic regulatory regions", 
      "promoter-reporter gene", 
      "DNA damaging agents", 
      "p53 target genes", 
      "death receptor gene", 
      "basal transcriptional activity", 
      "human papilloma virus E6", 
      "p53-dependent activation", 
      "p53-dependent transactivation", 
      "null cell line", 
      "p53-dependent manner", 
      "wild-type p53 protein", 
      "p53 protein", 
      "genomic loci", 
      "wild-type p53", 
      "genomic fragment", 
      "regulatory regions", 
      "target genes", 
      "DR5 gene", 
      "reporter gene", 
      "transcriptional activity", 
      "damaging agents", 
      "ATG site", 
      "intron 1", 
      "reporter plasmid", 
      "genes", 
      "apoptotic death", 
      "intron 2", 
      "receptor gene", 
      "mutant p53", 
      "luciferase expression", 
      "cell lines", 
      "transactivation", 
      "induction mechanism", 
      "DR5", 
      "promoter", 
      "protein", 
      "BS2", 
      "adenovirus vector", 
      "specific binding", 
      "p53", 
      "doxorubicin treatment", 
      "potential therapeutic agent", 
      "sites", 
      "loci", 
      "EMSA", 
      "reporter", 
      "plasmid", 
      "mutations", 
      "upstream", 
      "therapeutic agents", 
      "binding", 
      "expression", 
      "activity", 
      "fragments", 
      "activation", 
      "induction", 
      "receptors", 
      "E6", 
      "identification", 
      "mechanism", 
      "lines", 
      "manner", 
      "vector", 
      "region", 
      "agents", 
      "trails", 
      "death", 
      "cancer", 
      "radiation", 
      "results", 
      "treatment", 
      "protocol"
    ], 
    "name": "Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site", 
    "pagination": "1735-1743", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045600742"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1203489"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10777207"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1203489", 
      "https://app.dimensions.ai/details/publication/pub.1045600742"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_310.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1203489"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1203489'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1203489'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1203489'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1203489'


 

This table displays all metadata directly associated to this object as RDF triples.

259 TRIPLES      21 PREDICATES      130 URIs      112 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1203489 schema:about N1a26c996094a4386b822496e88b20a66
2 N27301a0cfbad4b00a2e047572559ac8a
3 N440ba5ce068d48c29677c23381d937a3
4 N5d009138b0914999b0bb3ec3b5026d33
5 N616eef0177ff4b138257c1e8f48488d5
6 N6f1450d789964291b5b23baf40a4640d
7 N8caa314cc5a946478ad8241e56bbc5c5
8 N96a7b5279dbe44e18667ec90a00c7ffd
9 Na961813afb5f41f6ba8d3a6eb205e55f
10 Naddaa0e972f9460f9a5c0f9822ffdebe
11 Nccfda96b1f584fb7b9edef2031e8125d
12 Ncf6a6f6eecf74762bfa95c8091905535
13 Ndc91dadce4944123b4879b1b57594756
14 Ne2fa177df0834decad74802a8d4c2a94
15 Nf6a5e5672c0849a29c08b7af8bccc032
16 Nf734986e5a414d1eb0013809816d6f68
17 Nfcf71135a63b4268a837dc9bd70b2127
18 anzsrc-for:11
19 anzsrc-for:1103
20 anzsrc-for:1112
21 schema:author N8aea629595134d5489305cde2023becc
22 schema:citation sg:pub.10.1038/362857a0
23 sg:pub.10.1038/38525
24 sg:pub.10.1038/ng0492-45
25 sg:pub.10.1038/ng1097-141
26 sg:pub.10.1038/nm0396-255a
27 sg:pub.10.1038/sj.onc.1201002
28 sg:pub.10.1038/sj.onc.1201264
29 sg:pub.10.1038/sj.onc.1201755
30 sg:pub.10.1038/sj.onc.1203025
31 schema:datePublished 2000-03-30
32 schema:datePublishedReg 2000-03-30
33 schema:description KILLER/DR5, a tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor gene, has been shown to be induced by DNA damaging agents and radiation in a p53-dependent manner. Although TRAIL is a potential therapeutic agent for cancer, the induction mechanism of its receptors is poorly understood. Here we show the identification of three p53 DNA-binding sites in the KILLER/DR5 genomic locus located upstream (BS1; −0.82 Kb) of the ATG site, within Intron 1 (BS2; +0.25 Kb downstream of the ATG) and within Intron 2 (BS3; +1.25 Kb downstream of the ATG). A modified p53-binding and immunoselection protocol using a wild-type p53-expressing adenovirus vector (Ad-p53) was used to identify the binding sites and to show that each binding site can bind specifically to wild-type p53 protein (wt-p53). A reporter assay revealed that only BS2 could enhance luciferase expression driven by a basal promoter. We constructed a reporter plasmid carrying the genomic regulatory region of KILLER/DR5 including the three p53 DNA-binding sites but no additional basal promoter. The genomic fragment showed basal transcriptional activity which was induced by wt-p53 but not by mutant p53, and human papilloma virus E6 inhibited the p53-dependent activation. Mutation of BS2 abrogated not only the binding activity of wt-p53 but also the induction of the KILLER/DR5 genomic promoter-reporter gene, indicating that BS2 is responsible for the p53-dependent transactivation of KILLER/DR5. In p53-wild-type but not -mutant or -null cell lines, doxorubicin treatment stabilized p53 protein, and increased specific binding to BS2 as revealed by EMSA, and upregulated the KILLER/DR5 promoter-luciferase reporter gene. These results suggest that the transactivation of KILLER/DR5 is directly regulated by exogenous or endogenous wt-p53 and establishes KILLER/DR5 as a p53 target gene that can signal apoptotic death.
34 schema:genre article
35 schema:isAccessibleForFree false
36 schema:isPartOf N3e9e094e81d04491bb72470805cfc751
37 Nf6902553762a4d08b4e26344722ee9f2
38 sg:journal.1097543
39 schema:keywords ATG site
40 BS2
41 DNA damaging agents
42 DNA-binding sites
43 DR5
44 DR5 gene
45 E6
46 EMSA
47 KILLER/DR5
48 activation
49 activity
50 adenovirus vector
51 agents
52 apoptotic death
53 basal promoter
54 basal transcriptional activity
55 binding
56 cancer
57 cell lines
58 damaging agents
59 death
60 death receptor gene
61 doxorubicin treatment
62 expression
63 fragments
64 genes
65 genomic fragment
66 genomic loci
67 genomic regulatory regions
68 human papilloma virus E6
69 identification
70 induction
71 induction mechanism
72 intron 1
73 intron 2
74 lines
75 loci
76 luciferase expression
77 manner
78 mechanism
79 mutant p53
80 mutations
81 null cell line
82 p53
83 p53 DNA-binding sites
84 p53 protein
85 p53 target genes
86 p53-dependent activation
87 p53-dependent manner
88 p53-dependent transactivation
89 plasmid
90 potential therapeutic agent
91 promoter
92 promoter-luciferase reporter gene
93 promoter-reporter gene
94 protein
95 protocol
96 radiation
97 receptor gene
98 receptors
99 region
100 regulatory regions
101 reporter
102 reporter gene
103 reporter plasmid
104 results
105 sites
106 specific binding
107 target genes
108 therapeutic agents
109 trails
110 transactivation
111 transcriptional activity
112 treatment
113 upstream
114 vector
115 wild-type p53
116 wild-type p53 protein
117 schema:name Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
118 schema:pagination 1735-1743
119 schema:productId N21979a01a74a48fd980bdbfc4425029a
120 Nc52ec1280b814f439684d3fb9fbc5b1a
121 Nd2a943c9d2214a2b94e26abadd6c684d
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045600742
123 https://doi.org/10.1038/sj.onc.1203489
124 schema:sdDatePublished 2022-10-01T06:30
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher N8ec6cb4285f041b39cc9435f301a5b65
127 schema:url https://doi.org/10.1038/sj.onc.1203489
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N08cb486efed8471f917ee3d4f04026f6 rdf:first sg:person.01320537310.58
132 rdf:rest rdf:nil
133 N1a26c996094a4386b822496e88b20a66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name DNA Damage
135 rdf:type schema:DefinedTerm
136 N21979a01a74a48fd980bdbfc4425029a schema:name pubmed_id
137 schema:value 10777207
138 rdf:type schema:PropertyValue
139 N27301a0cfbad4b00a2e047572559ac8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Tumor Suppressor Protein p53
141 rdf:type schema:DefinedTerm
142 N3e9e094e81d04491bb72470805cfc751 schema:issueNumber 14
143 rdf:type schema:PublicationIssue
144 N440ba5ce068d48c29677c23381d937a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Doxorubicin
146 rdf:type schema:DefinedTerm
147 N5d009138b0914999b0bb3ec3b5026d33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Tumor Cells, Cultured
149 rdf:type schema:DefinedTerm
150 N616eef0177ff4b138257c1e8f48488d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Mutagenesis
152 rdf:type schema:DefinedTerm
153 N6f1450d789964291b5b23baf40a4640d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 N8aea629595134d5489305cde2023becc rdf:first sg:person.01156250213.33
157 rdf:rest N08cb486efed8471f917ee3d4f04026f6
158 N8caa314cc5a946478ad8241e56bbc5c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name DNA
160 rdf:type schema:DefinedTerm
161 N8ec6cb4285f041b39cc9435f301a5b65 schema:name Springer Nature - SN SciGraph project
162 rdf:type schema:Organization
163 N96a7b5279dbe44e18667ec90a00c7ffd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Apoptosis
165 rdf:type schema:DefinedTerm
166 Na961813afb5f41f6ba8d3a6eb205e55f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Gene Expression
168 rdf:type schema:DefinedTerm
169 Naddaa0e972f9460f9a5c0f9822ffdebe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Receptors, TNF-Related Apoptosis-Inducing Ligand
171 rdf:type schema:DefinedTerm
172 Nc52ec1280b814f439684d3fb9fbc5b1a schema:name dimensions_id
173 schema:value pub.1045600742
174 rdf:type schema:PropertyValue
175 Nccfda96b1f584fb7b9edef2031e8125d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Binding Sites
177 rdf:type schema:DefinedTerm
178 Ncf6a6f6eecf74762bfa95c8091905535 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Introns
180 rdf:type schema:DefinedTerm
181 Nd2a943c9d2214a2b94e26abadd6c684d schema:name doi
182 schema:value 10.1038/sj.onc.1203489
183 rdf:type schema:PropertyValue
184 Ndc91dadce4944123b4879b1b57594756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Transcriptional Activation
186 rdf:type schema:DefinedTerm
187 Ne2fa177df0834decad74802a8d4c2a94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Promoter Regions, Genetic
189 rdf:type schema:DefinedTerm
190 Nf6902553762a4d08b4e26344722ee9f2 schema:volumeNumber 19
191 rdf:type schema:PublicationVolume
192 Nf6a5e5672c0849a29c08b7af8bccc032 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Receptors, Tumor Necrosis Factor
194 rdf:type schema:DefinedTerm
195 Nf734986e5a414d1eb0013809816d6f68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Oncogene Proteins, Viral
197 rdf:type schema:DefinedTerm
198 Nfcf71135a63b4268a837dc9bd70b2127 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Genes, Reporter
200 rdf:type schema:DefinedTerm
201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
202 schema:name Medical and Health Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
205 schema:name Clinical Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
208 schema:name Oncology and Carcinogenesis
209 rdf:type schema:DefinedTerm
210 sg:grant.2435689 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1203489
211 rdf:type schema:MonetaryGrant
212 sg:journal.1097543 schema:issn 0950-9232
213 1476-5594
214 schema:name Oncogene
215 schema:publisher Springer Nature
216 rdf:type schema:Periodical
217 sg:person.01156250213.33 schema:affiliation grid-institutes:grid.25879.31
218 schema:familyName Takimoto
219 schema:givenName R
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156250213.33
221 rdf:type schema:Person
222 sg:person.01320537310.58 schema:affiliation grid-institutes:grid.25879.31
223 schema:familyName El-Deiry
224 schema:givenName W S
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320537310.58
226 rdf:type schema:Person
227 sg:pub.10.1038/362857a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008690526
228 https://doi.org/10.1038/362857a0
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/38525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023661637
231 https://doi.org/10.1038/38525
232 rdf:type schema:CreativeWork
233 sg:pub.10.1038/ng0492-45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003183829
234 https://doi.org/10.1038/ng0492-45
235 rdf:type schema:CreativeWork
236 sg:pub.10.1038/ng1097-141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040087526
237 https://doi.org/10.1038/ng1097-141
238 rdf:type schema:CreativeWork
239 sg:pub.10.1038/nm0396-255a schema:sameAs https://app.dimensions.ai/details/publication/pub.1018355242
240 https://doi.org/10.1038/nm0396-255a
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/sj.onc.1201002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036533215
243 https://doi.org/10.1038/sj.onc.1201002
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/sj.onc.1201264 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015577678
246 https://doi.org/10.1038/sj.onc.1201264
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/sj.onc.1201755 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043632183
249 https://doi.org/10.1038/sj.onc.1201755
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/sj.onc.1203025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032194524
252 https://doi.org/10.1038/sj.onc.1203025
253 rdf:type schema:CreativeWork
254 grid-institutes:grid.25879.31 schema:alternateName Cancer Center and the Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA
255 Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA
256 schema:name Cancer Center and the Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA
257 Department of Medicine, Pharmacology, and Genetics, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA
258 Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania, PA, USA
259 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...